Tag: NIST

NTIA Seeks Comment on Federal Consumer Data Privacy Approach

Share

The Department of Commerce’s National Telecommunications and Information Administration (NTIA) issued a Notice seeking comments on a proposed federal consumer data privacy approach. In a parallel effort, the Commerce Department’s National Institute of Standards and Technology is developing a voluntary privacy framework to help organizations manage risk.

Continue reading

Enough of the Patchwork: Tech Industry Group Calls for a National Privacy Framework

Share

The Internet Association (IA), a group of 40 major internet and technology firms, called for the establishment of a national privacy framework anchored by six privacy principles on Wednesday. In its press release announcing the principles, the IA indicated its support for the American approach to federal privacy legislation that is “consistent nationwide, proportional, flexible, and encourages companies to act as good stewards of the personal information provided to them by individuals.”

Continue reading

Security Recommendations for Mobile Health Apps

Share

Expanded use of Electronic Health Records (EHRs) is an integral component of the ongoing modernization of the U.S. health care system through digitalization.  Among the anticipated advantages of using EHRs are improvements in patient care (e.g., through faster access to relevant information and consequently improved care coordination), increased patient engagement, as well as reduction of medical errors and cost savings. On the other hand, implementing EHRs in a sustainable and legally compliant way requires upfront investment in hardware, software, training, workflow restructuring, as well as management of risks unique to electronic records, such as vulnerability to malicious interference.  When EHRs are combined with mobile platforms, the cybersecurity risks multiply.  Addressing this latest challenge can be daunting, both for medical practices and EHR product providers.

Continue reading

US FDA Approaches to Artificial Intelligence

Share

Artificial Intelligence (AI) can be employed in a health care setting for a variety of tasks, from managing electronic health records at a hospital, to market research at a benefits management organization, to optimizing manufacturing operations at a pharmaceutical company. The level of regulatory scrutiny of such systems depends on their intended use and associated risks.

In the U.S., for medical devices using AI, one of the key regulatory bodies is the Food and Drug Administration (FDA), especially its Center for Devices and Radiological Health (CDRH). CDRH has long followed a risk-based approach in its regulatory policies, and has officially recognized ISO Standard 14971 “Application of Risk Management to Medical Devices.” That standard is over 10 years old now, and therefore is currently undergoing revisions – some of which are meant to address challenges posed by AI and other digital tools that are flooding the medical-devices arena.

Continue reading

© 2018 Drinker Biddle & Reath LLP. All Rights Reserved. Lawyer Advertising.

Disclaimer/Privacy Policy